Elsevier

Neuroscience

Volume 38, Issue 2, 1990, Pages 335-342
Neuroscience

Somatostatin-14 and somatostatin-28 inhibit calcium currents in rat neocortical neurons

https://doi.org/10.1016/0306-4522(90)90032-YGet rights and content

Abstract

The prosomatostatin-derived peptides, somatostatin-14 and somatostatin-28, are believed to function as neurotransmitters or neuromodulators in the cerebral cortex. To investigate the molecular mechanisms by which these peptides induce their physiological effects in the cerebral cortex, we have examined the effects of somatostatin-14 and somatostatin-28 on voltage-dependent Ca2+ currents in rat neocortical neurons in culture. Ca2+ currents were recorded using whole-cell patch-clamp techniques under conditions in which K+ and Na+ currents were blocked. Ca2+ currents were induced by depolarization from the holding potential of -80 mV. Somatostatin-14 (100 nM) and somatostatin-28 (100 nM) did not significantly affect low-voltage activated Ca2+ currents, but blocked high-voltage activated Ca2+ currents and slowed the activation of this current. The effects of both peptides were concentration-dependent and reversible. Furthermore, the effects of somatostatin-14 and somatostatin-28 on the high-voltage activated Ca2+ currents were not additive, suggesting that both peptides regulate this ionic current through similar cellular mechanisms. When patch pipettes used to record the Ca2+ currents contained 100 μ M cAMP and 0.5 mM isobutylmethylxanthine, a phosphodiesterase inhibitor, somatostatin-14 and somatostatin-28 still inhibited Ca2+ currents, indicating that the effects of these peptides on the Ca2+ currents were cAMP-independent. Inclusion of the non-hydrolysable guanine triphosphate analogue, guanine triphos-phate-gamma-thiol (500 μM) in the recording electrode produced effects similar to those induced by somatostatin-14 or somatostatin-28, suggesting the involvement of guanine nucleotide binding proteins in the actions of the peptides on the Ca2+ currents. This hypothesis is supported by the finding that pretreatment of the neurons with pertussis toxin greatly reduced the abilities of somatostatin-14 and somatostatin-28 to inhibit Ca2+ currents.

Our results suggest that somatostatin-14 and somatostatin-28 inhibit Ca2+ currents of rat neocortical neurons through a cAMP-independent mechanism involving pertussis toxin-sensitive guanine nucleotide binding proteins.

References (40)

  • SmithS.J. et al.

    Calcium ions, active zones and synaptic transmitter release

    Trends Neurosci.

    (1988)
  • TsienR.W. et al.

    Mechanism of calcium channel modulation by beta-adrenergic agents and dihydropyridine agonists

    J. molec. cell. Cardiol.

    (1986)
  • TsienR.W. et al.

    Multiple types of neuronal calcium channels and their selective modulation

    Trends Neurosci.

    (1988)
  • WatsonT.W.J. et al.

    Somatostatin-14 and somatostatin-28 but not somatostatin-28 (1–12) hyperpolarize CA1 pyramidal neurons in vitro

    Brain Res.

    (1988)
  • BeanB.

    Neurotransmitter inhibition of neuronal calcium currents by a change in channel voltage dependence

    Nature

    (1989)
  • DelfsJ. et al.

    Effects of somatostatin on the mammalian cortical neurons in culture: physiological actions and unusual dose response characteristics

    J. Neurosci.

    (1983)
  • GilmanA.G.

    G proteins: transducers of receptor-generated signals

    A. Rev. Biochem.

    (1987)
  • GothertM.

    Somatostatin selectively inhibits noradrenaline release from hypothalamic neurons

    Nature

    (1980)
  • GrayR. et al.

    Noradrenaline and beta-adrenoceptor agonist increase activity of voltage-dependent Ca2+ channels in hippocampal neurons

    Nature

    (1987)
  • GrayD.B. et al.

    Opiate and peptide inhibition of transmitter release in parasympathetic nerve terminals

    J. Neurosci.

    (1989)
  • Cited by (84)

    • Somatostatin in the dentate gyrus

      2007, Progress in Brain Research
      Citation Excerpt :

      This complexity in signaling is of course not unique to SST receptors, and simply because SST receptors have been shown that they can couple to a pathway in an artificial system, it does not necessarily follow that they do couple to these pathways to mediate their important physiological effects. Surprisingly few studies have addressed modulation of signaling pathways by SST in the brain, aside from its well-known actions on K+ and Ca2+ channels (Mihara et al., 1987; Inoue et al., 1988; Ikeda and Schofield, 1989; Wang et al., 1990a, b; Meriney et al., 1994; Connor et al., 1997; Sodickson and Bean, 1998). Inhibition of cAMP by SST in membranes from several brain regions has been observed, including cortex and hippocampus (Raynor and Reisine, 1992; Blake, 2001).

    • Somatostatin receptors

      2003, Biochimica et Biophysica Acta - Biomembranes
      Citation Excerpt :

      Both peptide isoforms were found to inhibit Ca2+ currents. But as to the regulation of K+ currents, not only did one study show lack of cross-desensitisation to SRIF-14 and SRIF-28; apparently, in another study, the two peptides also induced opposite effects on K+ currents [362,372,373]. As a rule, it is hard to make sense of such transmitter-specific transduction originating from the same receptors.

    • Endogenous somatostatin receptors mobilize calcium from inositol 1,4,5-trisphosphate-sensitive stores in NG108-15 cells

      2003, Brain Research
      Citation Excerpt :

      Five somatostatin receptor genes have been cloned. Some or all of these receptor subtypes have been observed to inhibit adenylate cyclase [53], activate K+ channels [47], and inhibit voltage-dependent Ca2+ channels [50]. These inhibitory actions underlie the decrease in neurotransmitter release and the reduced cellular excitability produced by somatostatin.

    View all citing articles on Scopus
    View full text